| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.0M | — |
| R&D Expense | $19.8M | -20.6% |
| SG&A Expense | $13.0M | +111.3% |
| Operating Income | -$30.7M | +1.0% |
| Net Income | -$27.9M | +8.6% |
| EPS (Basic) | -$2.66 | +98.4% |
| EPS (Diluted) | -$2.66 | +98.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $75.1M | — |
| Short-term Investments | $19.8M | -38.6% |
| Current Assets | $96.6M | +194.7% |
| Total Assets | $96.7M | +192.8% |
| Current Liabilities | $5.7M | +7.1% |
| Total Liabilities | $5.7M | +5.5% |
| Stockholders' Equity | $91.1M | +148.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.8M | +3.0% |
| Investing Cash Flow | $12.6M | +139.3% |
| Financing Cash Flow | $86.2M | — |